Last reviewed · How we verify

NCT06296511

The Influence of Acute Moderate-intensity Continuous Exercise on Appetite Regulation

Completed NA Last updated 6 March 2024
What this trial tests

NA trial testing Exercise in Obesity in 20 participants. Completed in 7 November 2023.

Timeline
23 June 2023
Primary endpoint
7 November 2023
7 November 2023

Quick facts

Lead sponsorLoughborough University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposebasic science
Enrollment20
Start date23 June 2023
Primary completion7 November 2023
Estimated completion7 November 2023
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Loughborough University

Who can join

Adults 18 to 40, any sex, with Obesity or Overweight. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A key area of obesity research has focused on the link between appetite, energy balance and weight control. Within this area, several appetite-related hormones and cellular cytokines have been identified as key signals influencing appetite and food intake. This includes the appetite-suppressing hormone oxyntomodulin (OXM) and a cellular stress-induced cytokine growth differentiation factor 15 (GDF-15). The aims of this study are: (1) to investigate the effect of acute moderate-intensity continuous exercise on oxyntomodulin and GDF-15 concentrations; (2) to investigate whether exercise-induced changes in circulating OXM and GDF-15 concentrations are correlated with subjective appetite perceptions and subsequent energy intake.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Loughborough University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06296511.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing